The decrease of miR-101 promoted cell proliferation, migration and invasion, and inhibited cell apoptosis by targeting Stmn1. These results suggest that miR-101 may act as a tumor suppressor and can be a novel candidate gene for the diagnosis and therapy to different subtypes of breast cancer. The gene discussed is STMN1; the disease is breast cancer.